Clinical trial
A Phase IV, Randomized Study to Evaluate the Immune Response of UK Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life
NCT00625677 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Randomized Study to Evaluate the Immune Response of UK Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life
- Lead sponsor
- Public Health England
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- March 31, 2010
- Enrollment
- 130 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.